Keywords
Last Name
Institution

Donald A. Smith

TitleASSOCIATE PROFESSOR
InstitutionMount Sinai
DepartmentCardiology
Address5 East 98th Street
3rd Floor
New York NY 10029
Phone212-427-1540
Fax212-996-0907
    Other Positions
    TitleASSOCIATE PROFESSOR
    InstitutionMount Sinai
    DepartmentPreventive Medicine


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Smith DA. ACP Journal Club. A lifestyle intervention did not reduce cardiovascular outcomes in overweight or obese patients with type 2 diabetes. Ann Intern Med. 2013 Oct 15; 159(8):JC4.
      View in: PubMed
    2. Greene J, Ashburn SM, Razzouk L, Smith DA. Greene et al. respond. Am J Public Health. 2013 Nov; 103(11):e4-5.
      View in: PubMed
    3. Ahmadian A, Verma S, Mundis GM, Oskouian RJ, Smith DA, Uribe JS. Minimally invasive lateral retroperitoneal transpsoas interbody fusion for L4-5 spondylolisthesis: clinical outcomes. J Neurosurg Spine. 2013 Sep; 19(3):314-20.
      View in: PubMed
    4. Greene J, Ashburn SM, Razzouk L, Smith DA. Fish oils, coronary heart disease, and the environment. Am J Public Health. 2013 Sep; 103(9):1568-76.
      View in: PubMed
    5. Smith DA. ACP Journal Club. Review: omega-3 polyunsaturated fatty acid supplements do not reduce major cardiovascular events in adults. Ann Intern Med. 2012 Dec 18; 157(12):JC6-5.
      View in: PubMed
    6. Deukmedjian AR, Dakwar E, Ahmadian A, Smith DA, Uribe JS. Early outcomes of minimally invasive anterior longitudinal ligament release for correction of sagittal imbalance in patients with adult spinal deformity. ScientificWorldJournal. 2012; 2012:789698.
      View in: PubMed
    7. Deukmedjian AR, Le TV, Baaj AA, Dakwar E, Smith DA, Uribe JS. Anterior longitudinal ligament release using the minimally invasive lateral retroperitoneal transpsoas approach: a cadaveric feasibility study and report of 4 clinical cases. J Neurosurg Spine. 2012 Dec; 17(6):530-9.
      View in: PubMed
    8. Uribe JS, Smith DA, Dakwar E, Baaj AA, Mundis GM, Turner AW, Cornwall GB, Akbarnia BA. Lordosis restoration after anterior longitudinal ligament release and placement of lateral hyperlordotic interbody cages during the minimally invasive lateral transpsoas approach: a radiographic study in cadavers. J Neurosurg Spine. 2012 Nov; 17(5):476-85.
      View in: PubMed
    9. Baaj AA, Dakwar E, Le TV, Smith DA, Ramos E, Smith WD, Uribe JS. Complications of the mini-open anterolateral approach to the thoracolumbar spine. J Clin Neurosci. 2012 Sep; 19(9):1265-7.
      View in: PubMed
    10. Le TV, Baaj AA, Dakwar E, Burkett CJ, Murray G, Smith DA, Uribe JS. Subsidence of polyetheretherketone intervertebral cages in minimally invasive lateral retroperitoneal transpsoas lumbar interbody fusion. Spine (Phila Pa 1976). 2012 Jun 15; 37(14):1268-73.
      View in: PubMed
    11. Baaj AA, Beckman J, Smith DA. O-Arm-based image guidance in minimally invasive spine surgery: technical note. Clin Neurol Neurosurg. 2013 Mar; 115(3):342-5.
      View in: PubMed
    12. Smith DA. ACP Journal Club. Adding niacin to simvastatin did not improve clinical outcomes in patients with CV disease and dyslipidemia. Ann Intern Med. 2012 Apr 17; 156(8):JC4-08.
      View in: PubMed
    13. Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, Shepherd MD, Seibel JA. American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. Endocr Pract. 2012 Mar-Apr; 18 Suppl 1:1-78.
      View in: PubMed
    14. Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, Shepherd MD, Seibel JA. American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: executive summary. Endocr Pract. 2012 Mar-Apr; 18(2):269-93.
      View in: PubMed
    15. Baaj AA, Smith DA, Vale FL, Uribe JS. Surgical approaches to thoracic ossification of the posterior longitudinal ligament. J Clin Neurosci. 2012 Mar; 19(3):349-51.
      View in: PubMed
    16. Le TV, Smith DA, Greenberg MS, Dakwar E, Baaj AA, Uribe JS. Complications of lateral plating in the minimally invasive lateral transpsoas approach. J Neurosurg Spine. 2012 Mar; 16(3):302-7.
      View in: PubMed
    17. Smith DA. ACP journal club. Meta-analysis: more intensive statin therapy prevents major vascular events. Ann Intern Med. 2011 May 17; 154(10):JC5-03.
      View in: PubMed
    18. Ehrlich AC, Smith DA. Abdominal diameter index and 12-year cardiovascular disease incidence in male bridge and tunnel workers. Int J Obes (Lond). 2011 Mar; 35(3):409-15.
      View in: PubMed
    19. Dakwar E, Cardona RF, Smith DA, Uribe JS. Early outcomes and safety of the minimally invasive, lateral retroperitoneal transpsoas approach for adult degenerative scoliosis. Neurosurg Focus. 2010 Mar; 28(3):E8.
      View in: PubMed
    20. Weinstein JS, Liu KC, Delashaw JB, Burchiel KJ, van Loveren HR, Vale FL, Agazzi S, Greenberg MS, Smith DA, Tew J. The safety and effectiveness of a dural sealant system for use with nonautologous duraplasty materials. J Neurosurg. 2010 Feb; 112(2):428-33.
      View in: PubMed
    21. Smith DA. The field of clinical lipidology. Preface. Endocrinol Metab Clin North Am. 2009 Mar; 38(1):xvii.
      View in: PubMed
    22. Lau JF, Smith DA. Advanced lipoprotein testing: recommendations based on current evidence. Endocrinol Metab Clin North Am. 2009 Mar; 38(1):1-31.
      View in: PubMed
    23. Mann D, Reynolds K, Smith D, Muntner P. Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines. Ann Pharmacother. 2008 Sep; 42(9):1208-15.
      View in: PubMed
    24. Smith DA. Is there less benefit from warfarin in diabetics after myocardial infarction? The numbing complexities of assessing anticoagulant and antiplatelet therapy in the diabetic patient. Cardiology. 2008; 111(3):158-60.
      View in: PubMed
    25. Smith D. Making sense of ENHANCE: ezetimibe (Zetia) lowers LDL cholesterol but doesn't decrease carotid intima-media thickness. Mt Sinai J Med. 2008 Mar-Apr; 75(2):143-7.
      View in: PubMed
    26. Smith DA. Subclavian stenosis was associated with an increase in all-cause and cardiovascular mortality at a mean of 9.4 years. Evid Based Med. 2008 Feb; 13(1):25.
      View in: PubMed
    27. Zesiewicz TA, Sullivan KL, Hoffmann M, Benes LM, Smith DA, Ward CL, Hauser RA. Delayed thalamic intracranial hemorrhage in an essential tremor patient following deep brain stimulation. Eur Neurol. 2008; 59(3-4):187-9.
      View in: PubMed
    28. Smith DA. Treatment of the dyslipidemia of insulin resistance. Med Clin North Am. 2007 Nov; 91(6):1185-210, x.
      View in: PubMed
    29. Tiyyagura SR, Smith DA. Standard lipid profile. Clin Lab Med. 2006 Dec; 26(4):707-32.
      View in: PubMed
    30. Smith DA, Galin I. Statin therapy for native and peri-interventional coronary heart disease. Curr Mol Med. 2006 Aug; 6(5):589-602.
      View in: PubMed
    31. Galin ID, Smith DA. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) Study. Am Heart J. 2006 May; 151(5):e1.
      View in: PubMed
    32. Pahwa R, Lyons KE, Wilkinson SB, Simpson RK, Ondo WG, Tarsy D, Norregaard T, Hubble JP, Smith DA, Hauser RA, Jankovic J. Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg. 2006 Apr; 104(4):506-12.
      View in: PubMed
    33. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Chaplin WF, Muntwyler J, Viles-Gonzalez JF, Weinberger J, Smith DA, Mizsei G, Badimon JJ. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol. 2005 Jul 5; 46(1):106-12.
      View in: PubMed
    34. Smith DA, Ness EM, Herbert R, Schechter CB, Phillips RA, Diamond JA, Landrigan PJ. Abdominal diameter index: a more powerful anthropometric measure for prevalent coronary heart disease risk in adult males. Diabetes Obes Metab. 2005 Jul; 7(4):370-80.
      View in: PubMed
    35. Smith DA. Picotamide reduced all-cause mortality more than aspirin in type 2 diabetes mellitus and peripheral arterial disease. ACP J Club. 2005 May-Jun; 142(3):61.
      View in: PubMed
    36. Smith DA. New trends in lipid management: eight cases to consider. Mt Sinai J Med. 2005 Mar; 72(2):90-9.
      View in: PubMed
    37. Smith DA. C-reactive protein was a moderate predictor of coronary heart disease. ACP J Club. 2004 Sep-Oct; 141(2):51.
      View in: PubMed
    38. Smith DA. Estrogen plus progestin reduced the incidence of diabetes in postmenopausal women with coronary heart disease. ACP J Club. 2003 Sep-Oct; 139(2):39.
      View in: PubMed
    39. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, Hellman R, Jellinger PS, Kendall D, Krauss RM, Neufeld ND, Petak SM, Rodbard HW, Seibel JA, Smith DA, Wilson PW. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003 May-Jun; 9(3):237-52.
      View in: PubMed
    40. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Smith D, Weinberger J, Wentzel J, Mizsei G, Mercuri M, Badimon JJ. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation. 2002 Dec 3; 106(23):2884-7.
      View in: PubMed
    41. Smith DA. Cardiovascular events were increased in high cardiovascular risk patients with albuminuria. ACP J Club. 2002 Jan-Feb; 136(1):34.
      View in: PubMed
    42. Smith DA, Harnick D, Kilaru R. Comparison of physician-managed lipid-lowering care in patients with coronary heart disease in two time periods (1994 and 1999). Am J Cardiol. 2001 Dec 15; 88(12):1417-9, A6.
      View in: PubMed
    43. Herbert R, Schechter C, Smith DA, Phillips R, Diamond J, Carroll S, Weiner J, Dahms TE, Landrigan PJ. Occupational coronary heart disease among bridge and tunnel officers. Arch Environ Health. 2000 May-Jun; 55(3):152-63.
      View in: PubMed
    44. Dangas G, Badimon JJ, Smith DA, Unger AH, Levine D, Shao JH, Meraj P, Fier C, Fallon JT, Ambrose JA. Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile. J Am Coll Cardiol. 1999 Apr; 33(5):1294-304.
      View in: PubMed
    45. Dangas G, Ambrose JA, D'Agate DJ, Shao JH, Chockalingham S, Levine D, Smith DA. Correlation of serum lipoprotein(a) with the angiographic and clinical presentation of coronary artery disease. Am J Cardiol. 1999 Feb 15; 83(4):583-5, A7.
      View in: PubMed
    46. Harnick DJ, Cohen JL, Schechter CB, Fuster V, Smith DA. Effects of practice setting on quality of lipid-lowering management in patients with coronary artery disease. Am J Cardiol. 1998 Jun 15; 81(12):1416-20.
      View in: PubMed
    47. Zschauer AO, Sielczak MW, Smith DA, Wanner A. Norepinephrine-induced contraction of isolated rabbit bronchial artery: role of alpha 1- and alpha 2-adrenoceptor activation. J Appl Physiol (1985). 1997 Jun; 82(6):1918-25.
      View in: PubMed
    Smith's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067